2-[(3R)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]-N-{[1-(propan-2-yl)-1H-benzimidazol-2-yl]methyl}acetamide
Chemical Structure Depiction of
2-[(3R)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]-N-{[1-(propan-2-yl)-1H-benzimidazol-2-yl]methyl}acetamide
2-[(3R)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]-N-{[1-(propan-2-yl)-1H-benzimidazol-2-yl]methyl}acetamide
Compound characteristics
Compound ID: | J100-0261 |
Compound Name: | 2-[(3R)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]-N-{[1-(propan-2-yl)-1H-benzimidazol-2-yl]methyl}acetamide |
Molecular Weight: | 405.46 |
Molecular Formula: | C22 H23 N5 O3 |
Smiles: | CC(C)n1c2ccccc2nc1CNC(C[C@@H]1C(Nc2ccccc2C(N1)=O)=O)=O |
Stereo: | ABSOLUTE |
logP: | 2.2087 |
logD: | 2.1963 |
logSw: | -3.0547 |
Hydrogen bond acceptors count: | 7 |
Hydrogen bond donors count: | 3 |
Polar surface area: | 87.674 |
InChI Key: | PSIZRUPONNOSLL-QGZVFWFLSA-N |